REFRACTORY OVARIAN CARCINOMA
Clinical trials for REFRACTORY OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for REFRACTORY OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough ovarian cancer: CBX-12 trial launches
Disease control Recruiting nowThis study tests a new drug called CBX-12 in 40 women with ovarian cancer that has stopped responding to platinum-based chemotherapy. The goal is to see if CBX-12 can shrink tumors or stop them from growing, and to check for side effects. Participants will receive one of two dose…
Matched conditions: REFRACTORY OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated May 26, 2026 03:35 UTC
-
Ovarian cancer Patients' own immune cells supercharged to fight tumors
Disease control Recruiting nowThis early-phase study tests a new treatment for ovarian cancer that has come back or not responded to standard therapy. Doctors take a patient's own immune cells (T cells), train them in a lab to recognize a protein called MUC1 found on cancer cells, and then give them back to t…
Matched conditions: REFRACTORY OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 13:54 UTC